Under the new measure, margins charged on the supply and sale of non-scheduled anti-cancer drugs will be limited to 30 per cent of their maximum retail price (MRP). These medicines fall outside the list of drugs covered by government-fixed ceiling prices

Experts said India does not have to choose between innovation and affordability. Instead, they called for public resources to focus on therapies that offer the greatest public health benefit